AstraZeneca Enhertu secures USFDA nod for HER2-low breast cancer Ruchika Sharma6 Aug 2022 2:30 PM ISTEnhertu is a HER2-directed ADC.
AstraZeneca- MSD gets EU nod for Lynparza to treat early-stage breast cancer Ruchika Sharma5 Aug 2022 5:23 PM ISTBreast cancer is the most diagnosed cancer worldwide with an estimated 2.3 million patients diagnosed in 2020.
AstraZeneca Covid jab Vaxzevria sales slide Ruchika Sharma1 Aug 2022 1:10 PM ISTThe group said annual revenue from Covid-19 medicines is anticipated to be broadly flat compared with 2021.
CDSCO Panel nod to AstraZeneca Olaparib for BRCA Mutated HER2 Negative Breast Cancer Rahul Verma26 July 2022 5:48 PM ISTBased on the scientific data provided by the drug maker AstraZeneca, the Subject Expert Committee (SEC) functional under Central Drug Standard Control...
AstraZeneca broadens haematological cancer pipeline with TeneoTwo acquisition Ruchika Sharma6 July 2022 12:30 PM ISTAstraZeneca will acquire all outstanding equity of TeneoTwo in exchange for an upfront payment of $100m on deal closing.
Wuxi Biologics takes step to getting off US 'unverified' trade list Ruchika Sharma5 July 2022 10:00 AM ISTNew Delhi: Wuxi Biologics, a Chinese company that makes ingredients for AstraZeneca's COVID-19 vaccine, may be a step closer to being taken off a U.S....
Oxford Biomedica signs new deal to make AstraZeneca COVID vaccine Ruchika Sharma3 July 2022 12:00 PM ISTOxford: Oxford Biomedica plc, a gene and cell therapy group, has announced that it has signed a new three year Master Services & Development...
AstraZeneca, Ionis Pharma seek US nod for Eplontersen after positive trial data Ruchika Sharma21 Jun 2022 3:35 PM ISTThe data from the 35-week interim analysis will be presented at an upcoming medical meeting later this year.
Researchers identify increase in serious neurological disorder cases following AstraZeneca vaccine Ruchika Sharma3 Jun 2022 3:23 PM ISTGuillain-Barre syndrome (GBS) is a rare but serious autoimmune condition that attacks the peripheral nervous system, typically resulting in numbness,...
AstraZeneca, RQ Biotechnology ink pact for monoclonal antibodies against coronavirus Ruchika Sharma18 May 2022 2:36 PM ISTUnder the agreement, AstraZeneca has acquired an exclusive worldwide licence to develop, manufacture and commercialise mAbs against SARS-CoV-2.
AstraZeneca booster effective against severe COVID: UK study Ruchika Sharma7 May 2022 10:00 AM ISTThe research supports the use of the AstraZeneca booster for protection against severe disease with COVID-19 in settings that have not yet offered...
AstraZeneca, Daiichi Sankyo get USFDA nod for Enhertu for earlier breast cancer use Ruchika Sharma6 May 2022 5:08 PM ISTThe approval was granted under the FDA's Real-Time Oncology Review (RTOR) programme and converts the accelerated approval of Enhertu in later line...
